Germany· DE-A57-ef4d6b81fb93abfb
Adreview
A medicinal product containing iodine (123i) iobenguane, registered in Germany by Ge Healthcare Buchler Gmbh & Co. Kg.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Iodine (123i) Iobenguane
- Manufacturer
- Ge Healthcare Buchler Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Iodine (123i) iobenguane in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAdreView Iobenguane (I-123)
- United KingdomAdreView [I-123] 111MBq/1.5ml solution for injection vialsGE Healthcare Ltd
- BelgiumAdreview 74 MBq/mlGE Healthcare
- NetherlandsAdreView, Iobenguane (123I) Injection, oplossing voor injectie 74 MBq/mlGE Healthcare B.V.
- PolandMetajodobenzyloguanidyna- 123 I (MIBG-123 I)Narodowe Centrum Badań Jądrowych
- United StatesAdreViewMedi-Physics Inc.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Adreview, Mibg (123i)
- Czechia · Mibg (I123) Curium Netherlands
- Denmark · Adreview, Mibg (123i) Curium Netherlands
- Spain · Adreview, Mibg (123i) Curium Pharma Spain
- France · Adreview (123i), Mibg (123i) Curium Netherlands
- United Kingdom (Northern Ireland) · Adreview, Mibg (123i) Curium Netherlands
- Hungary · [123i]-Mibg, [123i]-Mibg Curium Netherlands
- Ireland · Mibg (123i) Curium Netherlands
- Italy · [123i]-Mibg, Adreview
- Luxembourg · Adreview
- Netherlands · Adreview, Mibg (I123) Jobenguaan Curium Netherlands
- Norway · Adreview
- Slovakia · 123i Mibg Inj
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f7ab7dcb-f544-466e-8fcc-715e8a14e1ce GET /v1/drugs/f7ab7dcb-f544-466e-8fcc-715e8a14e1ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Iodine (123i) Iobenguane",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about iodine (123i) iobenguane.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.